Skip to main content
Log in

Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy

  • Original Research
  • Published:
Journal of Radiation Oncology

Abstract

Objectives

The objectives of this study were to compare the dosimetric differences between volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) techniques in treatment planning for liver stereotactic ablative body radiation (SABR) and, secondly, to identify when alternative VMAT arc configurations could provide dosimetric gains.

Methods

Ten consecutive patients previously treated with IMRT to a single liver lesion were selected and planned retrospectively using VMAT while employing the same dose objectives and dose constraints. Differences in dose conformality, normal liver sparing, and organs at risk (OARs) doses were compared between the IMRT and corresponding single circumferential arc (SCA) VMAT plan for each patient. Relative dosimetric differences were quantified for each of eight alternative VMAT arc configurations.

Results

The VMAT SCA plans were associated with a 4.8 and 8.1 % improvement of the 95 % conformity index (p = 0.02) and the 50 % gradient index (p = 0.05), respectively. A trend toward significance was found for normal liver sparing and the dose to the adjacent OAR with SCA vs. IMRT. The optimal VMAT arc arrangement was a single ipsilateral 180 degree arc in patients having small (<2–3 cm) lesions away from OARs (excluding the liver), a combination of coplanar arc and non-coplanar partial arc for patients with lesions adjacent to two or more critical OARs and an SCA which was sufficient for the remaining patients.

Conclusion

VMAT planning for liver SABR provided measurably higher levels of dose conformality compared with IMRT. An ipsilateral partial arc, single circumferential arc, or circumferential arc with added non-coplanar partial arc proved to be the most promising arc configuration in the majority of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Klein J, Dawson LA (2013) Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 87(1):22–32. doi:10.1016/j.ijrobp.2012.08.043

    Article  PubMed  Google Scholar 

  2. Timmerman RD, Herman J, Cho LC (2014) Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol 32(26):2847–2854. doi:10.1200/JCO.2014.55.4675

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hoyer M, Swaminath A, Bydder S, Lock M, Mendez Romero A, Kavanagh B, Goodman KA, Okunieff P, Dawson LA (2012) Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys 82(3):1047–1057. doi:10.1016/j.ijrobp.2011.07.020

    Article  PubMed  Google Scholar 

  4. Klein J, Korol R, Lo SS, Chu W, Lock M, Dorth JA, Ellis RJ, Mayr NA, Huang Z, Chung HT (2014) Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma. Future Oncol 10(14):2227–2241. doi:10.2217/fon.14.167

    Article  CAS  PubMed  Google Scholar 

  5. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591. doi:10.1200/JCO.2008.20.0600

    Article  PubMed  Google Scholar 

  6. Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE (2011) Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117(17):4060–4069. doi:10.1002/cncr.25997

    Article  PubMed  Google Scholar 

  7. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578. doi:10.1200/JCO.2008.19.6329

    Article  PubMed  Google Scholar 

  8. Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26(4):657–664. doi:10.1200/JCO.2007.14.3529

    Article  PubMed  Google Scholar 

  9. Bujold A, Dawson LA (2011) Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma. Cancer Radiother 15(1):54–63. doi:10.1016/j.canrad.2010.11.003

    Article  CAS  PubMed  Google Scholar 

  10. Chen D, Wang R, Meng X, Liu T, Yan H, Feng R, Liu S, Jiang S, Xu X, Zhu K, Dou X (2014) A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma. Radiat Oncol 9:48. doi:10.1186/1748-717X-9-48

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ (2011) Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol 6:76. doi:10.1186/1748-717X-6-76

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ogino R, Hosono M, Ishii K, Tatsumi D, Tsutsumi S, Miki Y, Masuoka Y, Shimatani Y, Miki Y (2013) A dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinoma. J Radiat Res 54(4):697–705. doi:10.1093/jrr/rrs139

    Article  PubMed  PubMed Central  Google Scholar 

  13. Park JM, Kim K, Chie EK, Choi CH, Ye SJ, Ha SW (2012) RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study. Br J Radiol 85(1015):e323–e329. doi:10.1259/bjr/19088580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tsai YC, Tsai CL, Hsu FM, Jian-Kuen W, Chien-Jang W, Cheng JC (2013) Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study. Med Dosim 38(4):366–371. doi:10.1016/j.meddos.2013.04.003

    Article  PubMed  Google Scholar 

  15. Wang PM, Hsu WC, Chung NN, Chang FL, Jang CJ, Fogliata A, Scorsetti M, Cozzi L (2014) Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. Radiat Oncol 9:18. doi:10.1186/1748-717X-9-18

    Article  PubMed  PubMed Central  Google Scholar 

  16. Helou J, Karotki A, Milot L, Chu W, Erler D, Chung HT (2015). 4DCT simulation with synchronized contrast injection in liver SBRT patients. Technol Cancer Res Treatment. doi:10.1177/1533034615572341

  17. Wang PM, Hsu WC, Chung NN, Chang FL, Fogliata A, Cozzi L (2013) Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments. Strahlenther Onkol 189(4):301–307. doi:10.1007/s00066-012-0298-6

    Article  PubMed  Google Scholar 

  18. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S94–S100. doi:10.1016/j.ijrobp.2009.06.092

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ, van As NJ (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14(1):e28–e37. doi:10.1016/S1470-2045(12)70510-7

    Article  PubMed  Google Scholar 

  20. Dong P, Lee P, Ruan D, Long T, Romeijn E, Yang Y, Low D, Kupelian P, Sheng K (2013) 4pi non-coplanar liver SBRT: a novel delivery technique. Int J Radiat Oncol Biol Phys 85(5):1360–1366. doi:10.1016/j.ijrobp.2012.09.028

    Article  PubMed  Google Scholar 

  21. Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Hoyer M (2011) Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncol 50(6):823–828. doi:10.3109/0284186X.2011.590526

    Article  PubMed  Google Scholar 

  22. Wu QJ, Thongphiew D, Wang Z, Chankong V, Yin FF (2008) The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer. Med Phys 35(4):1440–1451

    Article  PubMed  Google Scholar 

Download references

Funding information

This study was not supported by any research grant.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Ethical standards

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans T. Chung.

Additional information

Isabelle Thibault and Matt Wronski contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thibault, I., Wronski, M., Korol, R. et al. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy. J Radiat Oncol 5, 63–69 (2016). https://doi.org/10.1007/s13566-015-0220-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-015-0220-9

Keywords

Navigation